Back to JONES FINANCIAL COMPANIES LLLP JONES FINANCIAL COMPANIES LLLP

INBXINBX

2 quarters

Position history for JONES FINANCIAL COMPANIES LLLPJONES FINANCIAL COMPANIES LLLP's holdings in INHIBRX BIOSCIENCES INC

No. Jones Financial Companies exited its INBX (Inhibrx Biosciences) position in Q2 2025. Its Q1 2025 13F listed 4 shares worth $56. Jones Financial Companies first reported INBX in Q1 2025 and held it in 1 quarterly 13F filing.

Final Value

$0

Final Shares

0

Total Value Change

-$56

Total Shares Change

-4

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q2
Latest
Exited
0
-100.0%
$00.0%$14.43
0
2025-Q1
New
4
—
$560.0%$14.12
17

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used